Document is current
Any future updates will be listed below
-
Authors
Michel, Martin C. https://orcid.org/0000-0003-4161-8467
Pellegrino, Paolo
- License Information
-
More Information
Article History
Received: 12 March 2025
Accepted: 23 April 2025
First Online: 17 May 2025
Declarations
:
: Martin C. Michel is a paid consultant to Opella, a Sanofi company, on several projects including the project reflected in this manuscript. Martin C. Michel has not, however, received an honorarium for authorship of this paper. Paolo Pellegrino was an employee of Opella when this manuscript was prepared. Martin C. Michel is an Editorial Board member of Advances in Therapy. Martin C. Michel was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
